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Abstract. Methylation frequently occurs in cytosines of CpG sites to regulate gene expression. 
The identification of aberrant methylation of certain genes is important for cancer marker 
analysis. The aim of this study was to determine the methylation frequency in DNA samples of 
unknown length and/or concentration. Unmethylated cytosine is known to be converted to 
thymine following bisulfite treatment and subsequent PCR. For this reason, the AT content in 
DNA increases with an increasing number of methylation sites. In this study, the fluorescein-
carrying bis-acridinyl peptide (FKA) molecule was used for the detection of methylation 
frequency. FKA contains fluorescein and two acridine moieties, which together allow for the 
determination of the AT content of double-stranded DNA fragments. Methylated and 
unmethylated human genomes were subjected to bisulfide treatment and subsequent PCR using 
primers specific for the CFTR, CDH4, DBC1, and NPY genes. The AT content in the resulting 
PCR products was estimated by FKA, and AT content estimations were found to be in good 
agreement with those determined by DNA sequencing. This newly developed method may be 
useful for determining methylation frequencies of many PCR products by measuring the 
fluorescence in samples excited at two different wavelengths. 
1. Introduction 
Cancer-suppressing genes are inactivated by the aberrant methylation of cytosine in the CpG islands of 
their promoter regions [1]. Such inactivation leads to cancer via loss of physiological function of these 
genes or due to a loss of transcription factor activity resulting from secondary methylation of related 
genes [2]. The detection of methylation frequency in cancer-suppressing genes has thus become an 
important aspect of cancer diagnosis. Cytosine methylation can be detected by (1) bisulfite sequencing 
[3], (2) methylation-specific PCR [4], or (3) combined bisulfite restriction analysis (COBRA) methods 
[5]. These methods, however, have limitations such as time-consuming procedures with tedious steps 
and the formation of unclear internally formed PCR products or DNA sequencing capacity. To 
overcome these limitations, several improved methods have been developed [6-13]. To overcome the 
limitations of method 1, direct detection of methylated cytosine was assessed without bisulfite 
treatment. Okamoto and co-workers succeeded in detecting methylated cytosine based on the specific 
reaction with osmium complex [6], while Niwa and co-workers were able to discriminate between 
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methylated and unmethylated cytosine electrochemically based on differences in redox potentials [7]. 
Another approach was to use surface plasmon resonance (SPR) with a methylated cytosine-specific 
antibody [8]. Since unmethylated cytosine is converted to thymine after bisulfite treatment and 
subsequent PCR, the AT content is increased with increasing methylation frequency. Accordingly, 
methylation frequency can be determined based on Tm values of DNA compared with unmethylated 
DNA [9]. However, this method has a limitation that the amplification region for PCR analysis is 
subject to Tm value limitations, where higher Tm values are not measured accurately. The limitations 
associated with methods 2 and 3 were addressed by combining DNA hybridization after bisulfite 
treatment with subsequent PCR. We achieved electrochemical methylation detection in PCR products 
after bisulfite treatment coupled with DNA-immobilized electrode and ferrocenylnaphthalene diimide 
(FND) as a double-stranded DNA-specific ligand [10-13]. High sensitivity detection of the hybrid 
species was achieved using a surface-enhanced Raman scattering method [14]. Primer and target 
regions are discriminated precisely in these methods. Here, a bis-acridinyl peptide carrying fluorescein 
(FKA, Fig. 1A) [15] was applied to estimate methylation frequency in PCR products, where FKA 
exhibits almost no fluorescence in aqueous solutions because of intramolecular quenching by 
fluorescein being sandwiched between two acridine moieties. When FKA is bound to double-stranded 
DNA, the fluorescein of FKA is eliminated by the intercalation of the acridine portion of the peptide 
between the base pairs of the DNA duplex and thus the fluorescence is recovered. Interestingly, the 
fluorescence of fluorescein (λem = 517 nm) was observed via FRET when excited at 422 nm based on 
the acridine chromophore and this fluorescence correlated with AT content, since the acridine 
fluorescence was quenched due to binding to GC base pairs (Fig. 1B). The fluorescence (517 nm) 
obtained with an excitation wavelength of 492 nm, however, correlated with the amount of DNA 
present (Fig. 1B). The AT content of DNA was therefore estimated by the fluorescence ratio of 
ΔFI422:ΔFI492 (ΔFI422/ΔFI492) [15]. Since unmethylated cytosine is converted to thymine after bisulfite 
treatment and PCR, AT content differs between methylated and unmethylated PCR products. The AT 
content in DNA can be detected by FKA without knowing the DNA concentration and thus we 
hypothesized that FKA can be used to estimate the AT content of PCR products of unknown length 
and sequence. To confirm this hypothesis, the methylation frequencies in PCR products representing 
portions of the CDH4 [16], CFTR [17], DBC1 [17], and NPY [17] genes—all with different lengths 
and sequences—were assessed using FKA. 
 
2. Experimental 
2.1. Optimization of experimental conditions 
Fluorescence measurements were carried out using 96-well titer plates (Nunc) containing 100 μL/well 
of either blank solution (0.5 μM FKA, 5 mM Tris-HCl [pH 8.3], 0.5 mM EDTA) or test solution (20 
 
Fig. 1. (A) Chemical structure of the fluorometric peptide-type intercalator FKA and (B) the 
principle of AT content estimation with FKA. 
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μM (-bp) dsDNA, 0.5 μM FKA, 5 mM Tris-HCl (pH 8.3), and 0.5 mM EDTA) as well as 100 mM, 
200 mM, or 400 mM NaCl. A Molecular Devices SPECTRA MAX GEMINI XS instrument was used 
with excitation wavelengths of either 422 nm or 492 nm and an emission wavelength of 517 nm. 
Double-stranded DNA species with different AT contents were used: poly[(dA-dT)]2, Clostridium 
perfringens DNA, calf thymus DNA, Escherichia coli DNA, Micrococcus lysodeikticus DNA, and 
poly[(dG-dC)]2, which have known AT contents of 100%, 73%, 57%, 28%, and 0%, respectively. 
The fluorescence readings obtained were evaluated using equations 1, 2, and 3 below, where FIex.422, 
DNA and FIex.422, blank represent fluorescence at 517 nm when excited at 422 nm in the presence (DNA) 
or absence (blank) of DNA duplex, respectively; and FIex.492, DNA and FIex.492, blank represent fluorescence 
at 517 nm when excited at 492 nm in the presence (DNA) or absence (blank) of DNA duplex. 
ΔFI422 = FIex.422, DNA-FIex.422, blank  (1) 
ΔFI492 = FIex.492, DNA-FIex.492, blank  (2) 
From (1) and (2), F-Ratio = ΔFI422/ΔFI492  (3) 
 
2.2 Material collection 
Oligonucleotide template genes or PCR primers (Table 1) were purchased from Genenet (Fukuoka, 
Japan). The template DNA sequences of the CFTR gene were as follows [16]: methylated CFTR gene 
(CFTR-M), 5′-GTT TTG GGT TTG GCG GAT TTT GAC GCG AAG GAG GGT TTA GGA AGT TTT TCG 
GGG AGT CGG TTT TTT CGT CGG TGG TTT TTT TTG TTT TTT AGC GTT GTT AAT TGG ATT TAA 
AGA GAG GTC GGA TTG TCG TTT ATT TGC GGG-3′, unmethylated CFTR gene (CFRT-U): 5′-GGT 
TTT GGG TTT GGT GGA TTT TGA TGT GAA GGA GGG TTT AGG AAG TTT TTT GGG GAG 
TTG GTT TTT TTG TTG GTG GTT TTT TTT GTT TTT TAG TGT TGT TAA GAT TTA AAG 
AGA GGT TGT GAT TGT TGT TTA TTT GTG GGA TG-3′. CpGenomeTM Universal Methylated 
DNA (Lot PSO 1566253, Merck Millipore) and CpGenomeTM Universal Unmethylated DNA (Lot 
Number PSO 1579958, Merck Millipore) were used as methylated and unmethylated human genome 
DNA, respectively. The PrimeStar (TAKARA Bio) DNA polymerase was used to amplify 
oligonucleotide PCR templates, while ZymoTaq PreMix (Zymo research) was used to amplify 
genomic DNA after bisulfite treatment.  
 
2.3. Bisulfite treatment 
CpGenomeTM Universal Methylated DNA (Lot PSO 1566253) and CpGenomeTM Universal 
Unmethylated DNA (Lot Number PSO 1579958) were used as methylated and unmethylated samples, 
respectively. The above genomic DNA species (1.0 μg) were treated with the CpGenomeTM FAST 
DNA Modification Kit (Merck Millipore) according to the manufacturer’s instructions. The 
concentrations of the bisulfite-treated human genome templates were estimated by Nanodrop (Thermo 
Scientific) to be 22.9 ng/µl (Methylated, Lot PSO 1566253) and 17.4 ng/µl (Unmethylated, Lot 
Number PSO 1579958). 
 
2.4. Polymerase Chain Reaction (PCR) 
Table 1 shows the sequences of the primers used in PCR. Total reaction volumes of 100 µL were 
prepared: 4.0 µL CFTR-M (1 nM) or CFTR-U (1 nM) (or 1.0 µL of 22.9 or 17.4 ng/µL template 
DNA), 4 µL each of F- and R-primers (10 µM), and 50 µL PrimeStar (or ZymoTaq). PCR was carried 
out under the following conditions: 95°C for 5 min, followed by 30 cycles of 94°C for 15 sec, 
annealing temperature [different for each template] for 5 sec, and 72°C for 10 sec. The resulting PCR 
products were purified using a QIAquick PCR Purification Kit (QIAGEN) and were eluted in 30 µl 
elution buffer. The purified PCR products were assessed by 12.5% native polyacrylamide gel 
electrophoresis (PAGE). 
 
2.5. PCR product sequencing 
Sequencing of PCR products was carried out by Hokkaido System Science (Sapporo, Japan). 
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2.6. Fluorescence analysis of PCR products 
Fluorescence measurements were carried out in microtiter plates containing 100 µL/well of the 
following solution: 0.6 µM-bp PCR product, 0.5 µM FKA, 5 mM Tris-HCl (pH 8.3), and 0.5 mM 
EDTA as well as 100 mM, 200 mM, or 400 mM NaCl using a Molecular Devices SPECTRA MAX 
GEMINI XS instrument with excitation wavelengths of 422 nm or 492 nm and an emission 
wavelength of 517 nm. The resulting fluorescence values were evaluated using equation (3). 
 
 
Table 1. Primer sequences used in this experiment 
Name Sequence 
5'→3' 
Product 
size (bp) 
Tm 
(°C) 
PCR 
Cycles 
CFTR_MF GTTTTGGGTTTGGCGGATTTTGACGC 
142 46 56* 
40 
30* CFTR_MR CCCGCAAATAAACGACAATCGCGAC 
CFTR_UF GGTTTTGGGTTTGGTGGATTTTGATGT 
146 46 56* 
40 
30* CFTR_UF CATCCCACAAATAAACAACAATCACAAC 
CDH4_MF1 TTGTAGTTTCGAGCGCGC 
117 45  
40 
 CDH4_MR1 CCCGACTCCGAAAACCAAA 
CDH4_MF2 GTTTTCGGTGTCGGGTATC 
105 45  
40 
 CDH4_MR2 CGACAACTTACCCGAAACG 
DBC1_MF ACGCGATCCCTTTAAATACTCGTACG 
131 60 40 
DBC1_MR GAGGAGAGACGGGAGGTCGTTTCG 
NPY_MF TTAAAACCCTCTAACCGAAAACTTCCG 
131 45 40 
NPY_MR ACGATTAGCGCGGTATTTTCGTCGG 
*Custom Synthesized Template oligonucleotide 
Results and Discussion 
3.1 Optimization of detection conditions 
Fluorescence at 515 nm was measured for 20–50 μM-bp [poly(dA-dT)]2, calf Thymus DNA, or 
[poly(dG-dC)]2 using 0.50 μM FKA in 5 mM Tris-HCl (pH 8.3), 0.5 mM EDTA, and 200 mM NaCl 
excited at 422 nm or 492 nm and evaluated in terms of F-Ratio calculated by equation (3). F-Ratios 
were shown to differ depending on AT content, but were found to be stable at different DNA 
concentrations (Fig. 2). 
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Fig. 2. Estimation of AT content for DNA samples of unknown concentration. Black bar: [poly(A-
T)]2, gray bar: calf thymus DNA, white bar: [poly(dG-dC)]2. Experiments were carried out for 20–50 
µM-bp DNA in 5 mM Tris-HCl (pH 8.3), 0.5 mM EDTA, and 200 mM NaCl containing 0.5 μM FKA. 
 
Here, six different PCR products were prepared using four different genes (Table 1). These PCR 
products were fixed at a concentration of 0.6 µM per double-stranded DNA, while the PCR products 
of 105–146 bp in length corresponded to concentrations of 63–88 μM-bp and were thus subjected to 
AT content quantification using F-Ratio. In the next step, the effect of salt concentration on AT 
content estimation by FKA was assessed with NaCl concentrations of 100, 200, or 400 mM using 
poly[(dA-dT)]2, C. perfringens DNA, calf thymus DNA, E. coli DNA, M. lysodeikticus DNA, and 
poly[(dG-dC)]2 with AT contents of 100%, 73%, 57%, 28%, and 0%, respectively. Figure 3 shows that 
the F-Ratios varied with AT content and that the greatest change in F-Ratio was observed with 400 
mM NaCl for DNA with >50% AT content. Since these PCR products had AT contents of 37.8–65.1%, 
subsequent experiments were carried out with 400 mM NaCl. 
 
                
Figure 3. F-Ratio depends on AT content and NaCl concentration. Experiments were carried out 
with 20 μM DNA, 5 mM Tris-HCl (pH 8.3), 0.5 mM EDTA, 0.5 μM FKA, and NaCl at 100 (■), 200 
(○), or 400 (●) mM. 
 
 
3.2 AT content estimation using the model system 
As an initial trial use of the newly developed model system, AT content was estimated by FKA for 
assessing methylation frequency in the CFTR gene, the methylation of which is associated with bowel 
cancer [17]. The CFTR-M (AT content: 65.1%) and CFTR-U (AT content: 56.8%) DNA species were 
used as methylated and unmethylated CFTR genes following bisulfite treatment, after which PCR 
products were prepared using these DNA species as templates. A single band of ~140 bp in size was 
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obtained in native PAGE analysis of the PCR products (data not shown). F-Ratios of these PCR 
products were determined using FKA and were found to be 1.65 and 1.05 for the methylated and 
unmethylated samples, respectively, which is in agreement with the data shown in Fig. 3. The CFTR-
M and CFTR-U DNA species were combined at ratios of 0:1, 0.25:0.75, 0.5:0.5, 0.75:0.25, and 1:0 
ratio to yield AT contents of 65.1, 63.0, 61.0, 58.9, and 56.8%, respectively. The resulting F-Ratios are 
shown in Fig. 4 and were found to correlate well with the theoretical values (Fig. 3). 
 
              
Figure 4. Detection of methylation frequency in the CFTR gene by FKA. Experiments were 
carried out with 0.6 μM PCR product in 5 mM Tris-HCl (pH 8.3), 0.5 mM EDTA, and 400 mM 
NaCl containing 0.5 μM FKA. 
 
3.3 Methylation detection in genomic samples 
The CFTR, CDH4, DBC1, and NPY genes were subjected to PCR after bisulfite treatment. 
CpGenomeTM Universal Methylated DNA (Lot PSO 1566253) and CpGenomeTM Universal 
Unmethylated DNA (Lot Number PSO 1579958) were used as template DNA and the 
oligonucleotides listed in Table 1 were used as primers. The CFTR, CDH4, DBC1, and NPY genes 
correlate with bladder cancer, large intestinal cancer, lung cancer (non-small cell), and neuropeptide Y 
(a factor indirectly causing cancer), respectively. The resulting PCR products each yielded single 
bands of the expected sizes in native PAGE (data not shown). Although the methylation frequencies 
and AT contents of these products are not known, they were determined by DNA sequencing (Fig. A1). 
The AT contents of the PCR products are listed in Table 2, where the DNA sequencing results are 
shown together with the theoretical values (assuming completely methylated genomic DNA). The 
PCR products were then tested using the 0.5 µM FKA method and the resulting F-Ratios were plotted 
against AT content (Fig. 5). The resulting F-Ratios were in good agreement with the expected AT 
content, yielding good correlation between the two parameters. 
 
Table 2. AT content determined from DNA sequencing compared with theoretical values. 
AT content (%) CFTR-M CFTR-U CDH4 Region 1 
CDH4 
Region 2 DBC1 NPY 
Theoretical 56.8 65.1 37.8 42.9 43.5 59.5 
Based on sequencing 56.8 63.0 37.8 51.4 43.5 59.5 
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Fig. 5. Relationship between F-Ratio and AT content of methylated and unmethylated PCR 
products after bisulfite treatment. Experiments were carried out with 0.6 μM PCR product in 5 mM 
Tris-HCl (pH 8.3), 0.5 mM EDTA, and 400 mM NaCl containing 0.5 μM FKA. 
 
4. Conclusion 
Methylation frequency based on AT content was estimated by FKA for the CFTR, CDH4, DBC1, and 
NPY genes amplified from human genome samples subjected to bisulfite treatment. This method does 
not allow for the location of methylated site of PCR products to be determined; however, methylation 
frequency was estimated in double-stranded DNA samples of different lengths and/or unknown 
concentrations using this simple procedure. This newly developed method may be useful in 
determining methylation frequencies of many PCR products by simply measuring the fluorescence in 
samples excited at two different wavelengths. Furthermore, it is possible to estimate the methylation 
frequency in a DNA sample via real-time methods using an RT-PCR instrument and carrying out the 
reactions in the presence of FKA after bisulfite treatment of sample DNA. For this method to be 
effective in real-time, one would need to ensure that the polymerase is not inhibited during the PCR 
stage of the process. 
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